VERICEL CORPORATION - COMMON STOCK

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

25 окт 2023 08:30:00 Источник Nasdaq GlobeNewswire

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

28 сен 2023 08:30:00 Источник Nasdaq GlobeNewswire

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

20 сен 2023 16:30:00 Источник Nasdaq GlobeNewswire

Vericel to Present at the Morgan Stanley Global Healthcare Conference

06 сен 2023 08:30:00 Источник Nasdaq GlobeNewswire

Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

02 авг 2023 07:55:00 Источник Nasdaq GlobeNewswire

Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023

20 июл 2023 08:30:00 Источник Nasdaq GlobeNewswire

Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

10 май 2023 07:55:00 Источник Nasdaq GlobeNewswire

Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023

26 апр 2023 08:30:00 Источник Nasdaq GlobeNewswire

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023

28 фев 2023 08:30:00 Источник Nasdaq GlobeNewswire

Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance

23 фев 2023 07:55:00 Источник Nasdaq GlobeNewswire

Vericel to Report Fourth-Quarter 2022 Financial Results on February 23, 2023

09 фев 2023 08:00:01 Источник Nasdaq GlobeNewswire

Vericel Announces Preliminary Fourth-Quarter and Full-Year 2022 Financial Results and Accelerated Launch Timeline for MACI Arthroscopic Program

10 янв 2023 07:55:00 Источник Nasdaq GlobeNewswire

Vericel to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023

04 янв 2023 08:34:47 Источник Nasdaq GlobeNewswire

Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults

29 дек 2022 13:45:00 Источник Nasdaq GlobeNewswire

Vericel to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Service Forum and the Stephens Annual Investment Conference

10 ноя 2022 09:00:01 Источник Nasdaq GlobeNewswire

Vericel Reports Third Quarter 2022 Financial Results

09 ноя 2022 07:55:00 Источник Nasdaq GlobeNewswire

Vericel to Report Third-Quarter 2022 Financial Results on November 9, 2022

26 окт 2022 08:30:00 Источник Nasdaq GlobeNewswire

Vericel to Present at the Ladenburg Thalmann Healthcare Conference

22 сен 2022 08:30:00 Источник Nasdaq GlobeNewswire

Vericel to Present at the Morgan Stanley Global Healthcare and H.C. Wainwright Global Investment Conferences

06 сен 2022 08:30:00 Источник Nasdaq GlobeNewswire

Vericel Reports Second Quarter 2022 Financial Results

03 авг 2022 07:55:00 Источник Nasdaq GlobeNewswire